top of page


GLP-1 and the New Dynamics of the Pharmaceutical Industry: The Impact of Lilly and Novo Nordisk's Growth
The global pharmaceutical market is undergoing a significant transformation, driven by the growing sales of GLP-1 receptor agonists ,...
Feb 183 min read


50 New Drugs Approved by the FDA in 2024: Where is Pharmaceutical and Biotechnology Innovation Headed?
The FDA’s Center for Drug Evaluation and Research (CDER) 2024 annual report offers a fascinating insight into the rapid pace of...
Feb 24 min read


Exploring the Potential of Brazilian Biodiversity in Health
Brazil’s biodiversity, widely recognized as one of the richest in the world, offers a window of opportunity for innovative health...
Jan 264 min read
bottom of page
